Buspirone Hydrochloride Tablet
Product Images NDC 50268-135

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 50268-135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

15 (135 15 15mg)

15 (135 15 15mg)
This is the description for Buspirone Hydrochloride Tablets, USP, with NDC 50268-135-15, with each bottle containing 50 tablets (5 x 10) unit dose of Buspirone Hydrochloride. The usual dosage of the Buspirone Hydrochloride, USP is based on the prescribing information. It is pertinent to keep the drug and all other drugs out of the reach of children, and store at controlled room temperature. This drug is manufactured for MKARE, Pulaski, TN 38478. Additionally, it is important to note that the pharmacist should dispense with patient instructions sheet.*
FDA Label Image

Structural Formula (2a7745f5 4376 4a0a B040 Fdd441205d8d 01)

FDA Label Image

Figure (2a7745f5 4376 4a0a B040 Fdd441205d8d 02)

Figure (2a7745f5 4376 4a0a B040 Fdd441205d8d 02)
This text is a guide on how to split a tablet of either 15 mg or 30 mg as prescribed by a doctor. It gives the measurements for one side, two-thirds of the tablet, one-third of the tablet, and half of the tablet for both 15 mg and 30 mg tablets.*
FDA Label Image

Figure (2a7745f5 4376 4a0a B040 Fdd441205d8d 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.